Minh-Quan Le

Dr. Minh-Quan Le

Pharmaceutical Technology, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Hồ Chí Minh, Vietnam
orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 March 2025 in MedPharmRes
Verified
Journal Article
Open access
PDF file
MLMinh-Quan Le
Minh-Quan Le
KCKhuong-Nhi Cao-Nguyen
Khuong-Nhi Cao-Nguyen
KNKieu-Trinh Nguyen-Tran
Kieu-Trinh Nguyen-Tran
VNVan-Ha Nguyen
Van-Ha Nguyen
HLHau Le
Hau Le
Punch sticking is a common phenomenon in tablet manufacturing, often leading to tablet defects and compromise product quality. A thorough understanding of the sticking mechanism is essential to optimize the tablet production process. The aim of this study was to investigate the influence of formulations and punch properties on sticking. Seven model active pharmaceutical ingredients (APIs) (i.e., ibuprofen, aspirin, paracetamol, metronidazole, diltiazem, diclofenac, and cefuroxime) with various melting points and particle sizes were used to evaluate their propensity for sticking. The APIs stuck to punch were extracted and quantified using UV spectroscopy. The impact of fillers (i.e., microcrystalline cellulose, lactose monohydrate, dicalcium phosphate, pregelatinized starch, cellactose) and lubricants (i.e., magnesium stearate, stearic acid, aerosil, talc) were investigated. Additionally, the role of punch cup geometry (i.e., flat, standard concave, and deep concave) and punch materials was also investigated to determine their influence on sticking behaviour. Experimental results showed that the APIs with either a high melting point or small particle size have a lower tendency to stick. The differential scan calorimetry plots and X-ray diffraction graphs revealed changes in the crystalline structure due to compaction, which increased the tendency to stick. The excipients and API particle size influencede the degree of sticking. Chromium nitride-coated punches did not eliminate potential sticking at low compaction speeds. The flat-face punch demonstrated a higher sticking tendency than the concave punch. The factors contributing to sticking during tablet manufacturing were either ingredient properties, tableting parameters or both. Formulations containing MCC as a filler and utilizing deep concave punch were found to significantly reduce sticking tendencies compared to those with dicalcium phosphate filler and flat-faced punches.

10 April 2025 in Molecules
Verified
Journal Article
Open access
PDF file
TNTuan Duc Nguyen
Tuan Duc Nguyen
TLTrung Nguyên Nguyễn Lê
Trung Nguyên Nguyễn Lê
DNDuc Kien Ngo
Duc Kien Ngo
MKMinh Hien Khuu
Minh Hien Khuu
KTKhang Thien Tran
Khang Thien Tran
MLMinh-Quan Le
Minh-Quan Le
Vitexin and isovitexin are natural flavone C-glucosides that have numerous benefits for human health. However, their low oral bioavailability and poor gastrointestinal absorption dramatically restrict their potential medicinal uses. To overcome this challenge, chitosan-coated alginate microcapsules were prepared for intragastrical administration to rabbits. An LC-MS/MS method was developed and validated for the simultaneous determination of vitexin and isovitexin in the plasma of treated rabbits, using salicylic acid as the internal standard. Raw rabbit plasma samples were deproteinized using acetonitrile as a precipitation agent. Chromatographic separation was performed on a reversed-phase C18 column (100 mm × 4.6 mm, 3.5 µm), with an isocratic mobile solvent system comprising methanol and 0.1% acetic acid (40:60) as the mobile phase. All the analytes and the internal standard were ionized on a triple quadrupole mass spectrometer and electrospray ionization, operating in negative mode and multiple reaction monitoring. The analytical approach developed underwent validation in terms of system suitability, specificity, selectivity, LLOQ of 2 ng/mL, linearity (2.0–200 ng/mL, R2 > 0.99), accuracy (the intra- and inter-day from 94 to 110% with the relative standard deviations no more than 8.7%, precision with the recoveries from 97% to 102%, matrix effect (90–100%), carry-over, dilution integrity (2 times), and stability at room and frozen temperature for up to 1 month, and all the parameters met FDA and EMA requirements for bioanalytical methods. The validated procedure was applied to measure the absorption of vitexin and isovitexin from encapsulated extracts in a pilot pharmacokinetic study on rabbit plasma. Compared to the raw traditional extracts, the microcapsules enhanced the bioavailability of vi-texin and isovitexin regarding Cmax and AUC values.

24 June 2025 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
HMHuynh Nhu Mai
Huynh Nhu Mai
HDHoang-Han Do
Hoang-Han Do
TYTran Phi Hoang Yen
Tran Phi Hoang Yen
CNCong-Phi Nguyen
Cong-Phi Nguyen
VNVan-Ha Nguyen
Van-Ha Nguyen
MLMinh-Quan Le
Minh-Quan Le
Background/Objectives: Vitexin and isovitexin are bioactive flavonoids with promising pharmacological effects; however, they have poor bioavailability. Microencapsulation with biodegradable polymers is a promising strategy for improving their stability, bioavailability, and biocompatibility. This study aimed to optimize the formulation parameters to obtain microspheres with desired properties in terms of size, loading ratio, and vitexin–isovitexin release. Methods: Microspheres were prepared using alginate as the core matrix and a chitosan outer layer. A Design of Experiment approach using response surface methodology was employed. The hypoglycemic effects of the obtained microspheres were evaluated. Results: The formulation using 1.17% low-viscosity alginate, 7.60% calcium chloride, 5.78% Tween 80, and 5.00% Span 80 resulted in microspheres with optimal mean size (10.78 µm), high loading ratio (22.45%) and encapsulation efficiency (68.92%). The in vitro release of vitexin–isovitexin from microspheres was completed within 24 h in controlled manner. The microspheres were found to be non-toxic in vivo and exhibited hypoglycemic effects after 21 days at doses equivalent to 30 and 60 mg/kg of vitexin–isovitexin. The potential mechanisms might involve increasing the size of Islets of Langerhans and improving pancreatic β-cell function and insulin resistance, as observed in alloxan-induced diabetic mice. Conclusions: This work successfully developed alginate–chitosan-based microspheres for the controlled release of vitexin–isovitexin while maintaining their bioactivities.

23 January 2025 in Pharmacological Research - Modern Chinese Medicine
Verified
Journal Article
Open access
PPPhan Thi Kim Phung
Phan Thi Kim Phung
DBDang Ngoc Lam Binh
Dang Ngoc Lam Binh
NTNguyen Thi Anh Thu
Nguyen Thi Anh Thu
NHNguyen Van Ha
Nguyen Van Ha
THTran Thi Huyen
Tran Thi Huyen
MLMinh-Quan Le
Minh-Quan Le

22 March 2026 in Molecules
Verified
Journal Article
Open access
PDF file
QLQuoc-Viet Le
Quoc-Viet Le
KNKieu-Trinh Nguyen-Tran
Kieu-Trinh Nguyen-Tran
NPNgoc-Nhi Phuong
Ngoc-Nhi Phuong
DTDai-Phuc Phan Tran
Dai-Phuc Phan Tran
Van-An DuongVan-An Duong
Van-An Duong
MLMinh-Quan Le
Minh-Quan Le
Polyphenols, abundant compounds found in natural sources, exhibit various biological activities, including immunomodulatory properties that can either stimulate or suppress immune responses, making them promising for therapeutic applications. However, their poor solubility, low bioavailability, rapid metabolism, and non-specific distribution require advanced drug delivery strategies to overcome limitations in clinical translations. Therefore, nano-drug delivery systems have been intensively studied to explore the full therapeutic potential of polyphenols. Distinct from conventional paradigms where polyphenols serve solely as active compounds, this review advances the concept of polyphenol-based nanomedicine as dual-functional platforms: bioactive structural components and intrinsic immune modulators. Recent strategies to improve the loading efficacy of polyphenols, enhance their cellular uptake, prolong circulation, and enhance specific delivery based on those nanocarriers are emphasized. In addition, polyphenol-based nanoparticles, in which polyphenols serve as structural components, were also studied as self-therapeutics or multifunctional nanocarriers for drug delivery. We intensively focus on their immunomodulatory applications and highlight their potential in preclinical as well as clinical settings for the treatment of various diseases and therapeutic purposes, including autoimmune diseases, cancer immunotherapy, vaccination, inflammation, and infectious diseases. Although polyphenol nanoparticle development has made significant advances, there remain challenges in formulation stability, unclear in vivo toxicity profiles, and clinical translation. Further studies on optimizing nanoparticle design and assessing long-term toxicity are necessary to materialize their application. A combination of polyphenol nanoparticles with other immunotherapies may promise a pronounced efficacy and safety profile.

18 June 2025 in VNU Journal of Science: Medical and Pharmaceutical Sciences
Verified
Journal Article
Open access
PDF file
NTNguyen Huynh Tuyen
Nguyen Huynh Tuyen
HDHuynh Thi My Duyen
Huynh Thi My Duyen
NTNguyen Thi Anh Thu
Nguyen Thi Anh Thu
NTNguyen Tran Kieu Trinh
Nguyen Tran Kieu Trinh
NPNguyen Cong Phi
Nguyen Cong Phi
MLMinh-Quan Le
Minh-Quan Le
Gemfibrozil is a substance used in the treatment of hyperlipidemia. Unfortunately, it has poor solubility and high adhesiveness when tablet compressing. The study was conducted to prepare gemfibrozil 600 mg film-coated tablets that meet the dissolution specification according to USP 47. The research drug was also in vitro equivalent to the reference drug Lopid® 600 mg and reduced punch sticking. Some methods to increase the solubility of gemfibrozil (particle size reduction, such as milling, co-milling with surfactant, and preparing solid dispersions) were investigated. The melting method of preparing solid dispersion resulted in the best efficiency using poloxamer 407 as a polymer carrier. The tablets contained excipients as 6.7% poloxamer 407, 14.6% MCC 120, 4% croscarmellose sodium, 6% crospovidone, 1% stearyl fumarate, and 1% magnesium aluminum silicate, which had been proven to have dissolution profiles equivalent to Lopid®. On the other hand, the sticking problem was improved by using sodium stearyl fumarate as the lubricating excipient and using magnesium aluminum silicate as the absorbing excipient. The study suggested potential solutions that can be applied in preparing tablets containing active ingredients with poor solubility and causing the risk of punch sticking, such as gemfibrozil.